• FirefoxInstall the new Firefox »
  •  Dow Up0.86% Nasdaq Up0.90%

    AMAG Pharmaceuticals, Inc. (AMAG)

    -NasdaqGS
    49.70 Up 0.47(0.95%) 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Sep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 53,253   25,494   24,802   20,835  
    Cost of Revenue11,758  2,968  2,743  2,837  
    Gross Profit 41,495   22,526   22,059   17,998  
    Operating Expenses
    Research Development7,764  5,358  4,540  6,498  
    Selling General and Administrative25,604  12,875  16,284  17,491  
    Non Recurring11,501   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (3,374) 4,293   1,235   (5,991)
    Income from Continuing Operations
    Total Other Income/Expenses Net264  294  269  365  
    Earnings Before Interest And Taxes(3,110)4,587  1,504  (5,626)
    Interest Expense7,041  3,129  3,051  1,476  
    Income Before Tax(10,151)1,458  (1,547)(7,102)
    Income Tax Expense(153,159) -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops143,008  1,458  (1,547)(7,102)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income 143,008   1,458   (1,547) (7,102)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares 143,008   1,458   (1,547) (7,102)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.